Johnson & Johnson to Participate in the Guggenheim Global Healthcare Conference
Johnson & Johnson (NYSE: JNJ) has announced its participation in the Guggenheim Global Healthcare Conference on Tuesday, November 12th, at the InterContinental Boston. Biljana Naumovic, President of Solid Tumor, U.S. Oncology, and Mark Wildgust, Vice President of Global Medical Affairs Oncology, will represent the company in a session scheduled for 10:30 a.m. (Eastern Time).
A live audio webcast of the session will be available to investors and interested parties on the Johnson & Johnson website at www.investor.jnj.com. An audio replay will be accessible approximately 48 hours after the webcast. This event provides an opportunity for stakeholders to gain insights into JNJ's oncology initiatives and healthcare strategies.
Johnson & Johnson (NYSE: JNJ) ha annunciato la sua partecipazione alla Guggenheim Global Healthcare Conference martedì 12 novembre, presso l'InterContinental di Boston. Biljana Naumovic, Presidente del Tumore Solido, Oncologia U.S., e Mark Wildgust, Vicepresidente delle Affari Medici Globali Oncologici, rappresenteranno l'azienda in una sessione programmata per le 10:30 (ora orientale).
Un webcast audio in diretta della sessione sarà disponibile per investitori e parti interessate sul sito web di Johnson & Johnson all'indirizzo www.investor.jnj.com. Una registrazione audio sarà accessibile circa 48 ore dopo il webcast. Questo evento offre un'opportunità per gli stakeholder di acquisire informazioni sulle iniziative oncologiche e sulle strategie sanitarie di JNJ.
Johnson & Johnson (NYSE: JNJ) ha anunciado su participación en la Guggenheim Global Healthcare Conference el martes 12 de noviembre, en el InterContinental Boston. Biljana Naumovic, Presidenta de Tumores Sólidos, Oncología de EE.UU., y Mark Wildgust, Vicepresidente de Asuntos Médicos Globales de Oncología, representarán a la empresa en una sesión programada para las 10:30 a.m. (hora del Este).
Una transmisión en vivo por audio de la sesión estará disponible para inversores y partes interesadas en el sitio web de Johnson & Johnson en www.investor.jnj.com. Una repetición de audio estará accesible aproximadamente 48 horas después de la transmisión. Este evento brinda una oportunidad para que los interesados obtengan información sobre las iniciativas oncológicas y estrategias de salud de JNJ.
존슨 & 존슨 (NYSE: JNJ)은 11월 12일 화요일, 보스턴 인터컨티넨탈에서 열리는 구겐하임 글로벌 헬스케어 컨퍼런스에 참가한다고 발표했습니다. 빌야나 나우모비치, 미국 종양학의 고형 종양 회장과 마크 와일드구스트, 글로벌 의료 업무 부사장이 오전 10시 30분(동부 표준시) 세션에서 회사를 대표합니다.
이 세션의 실시간 오디오 웹캐스트는 투자자 및 이해관계자들이 www.investor.jnj.com을 통해 Johnson & Johnson 웹사이트에서 이용할 수 있습니다. 오디오 재생은 웹캐스트 후 약 48시간 후에 접근할 수 있습니다. 이 이벤트는 이해관계자들에게 JNJ의 종양학 이니셔티브 및 헬스케어 전략에 대한 통찰을 얻을 수 있는 기회를 제공합니다.
Johnson & Johnson (NYSE: JNJ) a annoncé sa participation à la Guggenheim Global Healthcare Conference le mardi 12 novembre, à l'InterContinental de Boston. Biljana Naumovic, Présidente des Tumeurs Solides, Oncologie États-Unis, et Mark Wildgust, Vice-Président des Affaires Médicales Globales en Oncologie, représenteront l'entreprise lors d'une session programmée à 10h30 (heure de l'Est).
Un webcast audio en direct de la session sera disponible pour les investisseurs et les parties intéressées sur le site Web de Johnson & Johnson à l'adresse www.investor.jnj.com. Un enregistrement audio sera accessible environ 48 heures après le webdiffusion. Cet événement offre aux parties prenantes une opportunité d'acquérir des informations sur les initiatives oncologiques et les stratégies de santé de JNJ.
Johnson & Johnson (NYSE: JNJ) hat seine Teilnahme an der Guggenheim Global Healthcare Conference am Dienstag, den 12. November, im InterContinental Boston angekündigt. Biljana Naumovic, Präsidentin für soliden Tumoren, US-Onkologie, und Mark Wildgust, Vizepräsident für globale medizinische Angelegenheiten in der Onkologie, werden das Unternehmen in einer für 10:30 Uhr (Eastern Time) geplanten Sitzung vertreten.
Ein live Audio-Webcast der Sitzung wird für Investoren und Interessierte auf der Johnson & Johnson-Website unter www.investor.jnj.com verfügbar sein. Eine Audio-Wiederholung wird ungefähr 48 Stunden nach dem Webcast zugänglich sein. Diese Veranstaltung bietet den Stakeholdern die Möglichkeit, Einblicke in die Onkologie-Initiativen und Gesundheitsstrategien von JNJ zu erhalten.
- None.
- None.
This live audio webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.
The audio webcast replay will be available approximately 48 hours after the webcast.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241004735017/en/
Media contact:
media-relations@its.jnj.com
Investor contact:
investor-relations@its.jnj.com
Source: Johnson & Johnson
FAQ
When is Johnson & Johnson (JNJ) participating in the Guggenheim Global Healthcare Conference?
Who will represent Johnson & Johnson (JNJ) at the Guggenheim Global Healthcare Conference?
What time is Johnson & Johnson's (JNJ) session at the Guggenheim Global Healthcare Conference?
How can investors access Johnson & Johnson's (JNJ) webcast from the Guggenheim Global Healthcare Conference?
When will the replay of Johnson & Johnson's (JNJ) conference session be available?
